SE8002602L - Diagnostiskt forfarande - Google Patents

Diagnostiskt forfarande

Info

Publication number
SE8002602L
SE8002602L SE8002602A SE8002602A SE8002602L SE 8002602 L SE8002602 L SE 8002602L SE 8002602 A SE8002602 A SE 8002602A SE 8002602 A SE8002602 A SE 8002602A SE 8002602 L SE8002602 L SE 8002602L
Authority
SE
Sweden
Prior art keywords
serum
dna
cancer
diagnostic procedure
human beings
Prior art date
Application number
SE8002602A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Inventor
S T Crooke
L Galvan
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE8002602L publication Critical patent/SE8002602L/

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5755Immunoassay; Biospecific binding assay; Materials therefor for cancer of the uterine cervix, uterine corpus or endometrium
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875Nucleoproteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4703Regulators; Modulating activity
    • G01N2333/4704Inhibitors; Supressors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475Assays involving growth factors
    • G01N2333/50Fibroblast growth factors [FGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Sink And Installation For Waste Water (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE8002602A 1979-04-10 1980-04-03 Diagnostiskt forfarande SE8002602L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2873279A 1979-04-10 1979-04-10

Publications (1)

Publication Number Publication Date
SE8002602L true SE8002602L (sv) 1980-12-09

Family

ID=21845111

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8002602A SE8002602L (sv) 1979-04-10 1980-04-03 Diagnostiskt forfarande

Country Status (24)

Country Link
JP (1) JPS55143441A (de)
KR (1) KR830002502A (de)
AR (1) AR222700A1 (de)
AT (1) AT365343B (de)
AU (1) AU536522B2 (de)
BE (1) BE882669A (de)
CH (1) CH644453A5 (de)
DE (1) DE3013837A1 (de)
DK (1) DK149980A (de)
ES (1) ES8103380A1 (de)
FI (1) FI801078A7 (de)
FR (1) FR2454099A1 (de)
GB (1) GB2047712B (de)
GR (1) GR67692B (de)
HU (1) HU183122B (de)
IE (1) IE49981B1 (de)
IL (1) IL59772A (de)
IT (1) IT1143135B (de)
LU (1) LU82345A1 (de)
NL (1) NL8002094A (de)
NO (1) NO801018L (de)
PH (1) PH15637A (de)
SE (1) SE8002602L (de)
ZA (1) ZA802141B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3524644A1 (de) * 1985-07-10 1987-01-15 Heyl Chem Pharm Undulin und dessen peptidfragmente, verfahren zu deren herstellung und ihre verwendung

Also Published As

Publication number Publication date
FI801078A7 (fi) 1981-01-01
KR830002502A (ko) 1983-05-30
IL59772A (en) 1983-05-15
GB2047712A (en) 1980-12-03
IE800693L (en) 1980-10-10
DK149980A (da) 1980-10-11
IT8048370A0 (it) 1980-04-09
NO801018L (no) 1980-10-13
AU5719380A (en) 1980-10-16
AR222700A1 (es) 1981-06-15
CH644453A5 (fr) 1984-07-31
HU183122B (en) 1984-04-28
BE882669A (fr) 1980-10-06
AT365343B (de) 1982-01-11
AU536522B2 (en) 1984-05-10
NL8002094A (nl) 1980-10-14
IL59772A0 (en) 1980-06-30
ZA802141B (en) 1981-04-29
IE49981B1 (en) 1986-01-22
JPS55143441A (en) 1980-11-08
GR67692B (de) 1981-09-07
IT1143135B (it) 1986-10-22
ATA195780A (de) 1981-05-15
FR2454099A1 (fr) 1980-11-07
ES490396A0 (es) 1981-02-16
FR2454099B1 (de) 1984-01-27
LU82345A1 (fr) 1980-12-16
PH15637A (en) 1983-03-11
GB2047712B (en) 1983-02-23
ES8103380A1 (es) 1981-02-16
DE3013837A1 (de) 1980-10-30

Similar Documents

Publication Publication Date Title
SE8000469L (sv) Vevnadsbindmedel och forfarande for dess framstellning samt bindmedlets anvendning
DK0733067T3 (da) N-terminalt kemisk modificerede proteinpræparater og fremgangsmåder
SE8601135D0 (sv) Kemiskt modifierat hyaluronsyrapreparat och metod for utvinning derav ur djurvevnader
SE8902376D0 (sv) Foerfarande foer framstaellning av ett vaevnadsbindemedel
DK524187A (da) Aminosyrechelaterede midler til udlevering til specifikke biologiske vaevssteder
ES2150936T3 (es) Deteccion inmunoquimica de productos finales de glucosilacion avanzada in vivo.
ZA872166B (en) Synthetic htlv-iii peptides,compositions and uses thereof
DE3687741D1 (de) Geraet zur ultraschallechographie der bewegung von koerperorganen, insbesondere der blutstroemung oder des herzens.
ES2045216T3 (es) Inmunoensayo y derivados polimeros de igg para la compensacion de factores de perturbacion en el inmunoensayo.
KR890007750A (ko) 인간 조직 인자 억제제의 dna 클론
DE68923291D1 (de) Antikörper-konjugate mit zwei oder mehr kovalent vernetzten fc-regionen.
DE3650135D1 (de) Proteingewinnung.
BG35465A3 (en) Method for preparing derivatives of 1-(cyclohexyl)-4-aryl-4- piperidine carbonic acid
BR8504469A (pt) Componentes acrescentados ao concreto
ATE120372T1 (de) Antikörper für die antilymphozyten- antikörpertherapie.
BG49827A3 (bg) Метод за получаване на пречистен биологично активен рекомбинантен човешки колоний стимулиращ фактор
ES8403623A1 (es) Procedimiento para la determinacion de bilirrubina directa y total en liquidos corporales.
ATE13767T1 (de) Protein (pp16), verfahren zu seiner anreicherung und gewinnung sowie seine verwendung.
AU567747B2 (en) Early detection of mammalian pregnancy
ES511982A0 (es) "procedimiento para la preparacion de plasminogeno practicamente exento de virus de hepatitis".
DE69129747D1 (de) In lösung bringen von proteinen in aktiver form
SE8002602L (sv) Diagnostiskt forfarande
PT86944A (pt) Verfahren zur isolierung von basalmembranproteinen aus menschlichen und tierischen geweben
DK242688D0 (da) Hydraulisk bindemiddel
ES8505915A1 (es) Metodo de preparar dimetiloctenonas

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8002602-4